This observational study, run by New York Cancer and Blood Specialists (NYCBS), is collecting human biological samples (biospecimens) and health information from a large number of people. The goal is to create a resource that researchers can use to develop new ways to detect diseases earlier and create better treatments for various conditions, including cancer. You can join if you are at least 18 years old and can provide informed consent. You may or may not have an active disease, and samples can come from people with benign (non-cancerous) conditions, those with cancer or other diseases, or healthy individuals. The study aims to develop new diagnostic tools and treatments to improve the quality and length of life for people with diseases, with results expected in 10 years.

Study design

This is an observational study with a planned enrollment of 900,000 participants. It is collecting biological samples and associated data.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary goal of developing new diagnostics and treatments is measured at 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.